Dr. Lal PathLabs Limited

NSEI:LALPATHLAB Stock Report

Market Cap: ₹254.4b

Dr. Lal PathLabs Valuation

Is LALPATHLAB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of LALPATHLAB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: LALPATHLAB (₹3053.65) is trading above our estimate of fair value (₹1321.74)

Significantly Below Fair Value: LALPATHLAB is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for LALPATHLAB?

Key metric: As LALPATHLAB is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for LALPATHLAB. This is calculated by dividing LALPATHLAB's market cap by their current earnings.
What is LALPATHLAB's PE Ratio?
PE Ratio63.4x
Earnings₹4.01b
Market Cap₹254.41b

Price to Earnings Ratio vs Peers

How does LALPATHLAB's PE Ratio compare to its peers?

The above table shows the PE ratio for LALPATHLAB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average67.9x
VIJAYA Vijaya Diagnostic Centre
94.4x25.4%₹125.2b
METROPOLIS Metropolis Healthcare
71.4x23.8%₹105.7b
539871 Thyrocare Technologies
60.4x26.9%₹50.7b
KRSNAA Krsnaa Diagnostics
45.4x35.5%₹31.4b
LALPATHLAB Dr. Lal PathLabs
63.4x13.6%₹254.4b

Price-To-Earnings vs Peers: LALPATHLAB is good value based on its Price-To-Earnings Ratio (63.4x) compared to the peer average (67.9x).

Price to Earnings Ratio vs Industry

How does LALPATHLAB's PE Ratio compare vs other companies in the IN Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.1xn/aUS$11.76m
542918 Gian Life Care
4.9xn/aUS$2.33m
No more companies available in this PE range
LALPATHLAB 63.4xIndustry Avg. 41.9xNo. of Companies5PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: LALPATHLAB is expensive based on its Price-To-Earnings Ratio (63.4x) compared to the Indian Healthcare industry average (41.9x).

Price to Earnings Ratio vs Fair Ratio

What is LALPATHLAB's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LALPATHLAB PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio63.4x
Fair PE Ratio50.9x

Price-To-Earnings vs Fair Ratio: LALPATHLAB is expensive based on its Price-To-Earnings Ratio (63.4x) compared to the estimated Fair Price-To-Earnings Ratio (50.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst LALPATHLAB forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹3,053.65
₹3,210.13
+5.1%
13.4%₹3,770.00₹2,286.00n/a23
Nov ’25₹3,087.80
₹3,210.13
+4.0%
13.4%₹3,770.00₹2,286.00n/a23
Oct ’25₹3,415.65
₹3,134.09
-8.2%
14.5%₹3,770.00₹2,286.00n/a23
Sep ’25₹3,417.40
₹3,134.09
-8.3%
14.5%₹3,770.00₹2,286.00n/a23
Aug ’25₹3,099.00
₹2,606.18
-15.9%
11.4%₹3,500.00₹2,141.00n/a22
Jul ’25₹2,823.50
₹2,542.67
-9.9%
9.2%₹2,900.00₹2,141.00n/a21
Jun ’25₹2,647.85
₹2,514.29
-5.0%
11.6%₹2,900.00₹1,695.00n/a21
May ’25₹2,372.45
₹2,449.30
+3.2%
11.3%₹2,900.00₹1,670.00n/a20
Apr ’25₹2,288.20
₹2,439.00
+6.6%
12.9%₹3,181.00₹1,670.00n/a18
Mar ’25₹2,328.10
₹2,420.39
+4.0%
13.9%₹3,181.00₹1,670.00n/a18
Feb ’25₹2,499.60
₹2,378.50
-4.8%
16.1%₹3,181.00₹1,564.00n/a18
Jan ’25₹2,575.35
₹2,387.06
-7.3%
14.4%₹3,080.00₹1,676.00n/a17
Dec ’24₹2,743.05
₹2,371.67
-13.5%
14.4%₹3,080.00₹1,676.00n/a18
Nov ’24₹2,380.70
₹2,178.17
-8.5%
17.0%₹2,800.00₹1,432.00₹3,087.8018
Oct ’24₹2,524.35
₹2,164.83
-14.2%
17.1%₹2,800.00₹1,432.00₹3,415.6518
Sep ’24₹2,201.25
₹2,119.32
-3.7%
16.9%₹2,735.00₹1,432.00₹3,417.4019
Aug ’24₹2,348.70
₹2,104.05
-10.4%
17.3%₹2,735.00₹1,432.00₹3,099.0019
Jul ’24₹2,259.40
₹1,939.79
-14.1%
17.9%₹2,525.00₹1,187.00₹2,823.5019
Jun ’24₹2,005.35
₹1,953.50
-2.6%
17.6%₹2,525.00₹1,187.00₹2,647.8520
May ’24₹1,954.50
₹2,033.05
+4.0%
17.2%₹2,710.00₹1,500.00₹2,372.4519
Apr ’24₹1,828.10
₹2,044.63
+11.8%
17.0%₹2,710.00₹1,500.00₹2,288.2019
Mar ’24₹1,970.05
₹2,038.30
+3.5%
17.4%₹2,735.00₹1,500.00₹2,328.1020
Feb ’24₹2,052.50
₹2,192.45
+6.8%
20.5%₹2,911.00₹1,400.00₹2,499.6020
Jan ’24₹2,260.45
₹2,215.84
-2.0%
20.8%₹2,952.00₹1,400.00₹2,575.3519
Dec ’23₹2,438.75
₹2,215.84
-9.1%
20.8%₹2,952.00₹1,400.00₹2,743.0519
Nov ’23₹2,612.35
₹2,225.53
-14.8%
21.3%₹3,000.00₹1,400.00₹2,380.7019

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Medico Intercontinental

₹592.5m

Trades in pharmaceutical products.

539938

₹59.25

7D

28.6%

1Y

-37.0%

Dr Lalchandani Labs

₹78.0m

Provides diagnostic and related healthcare tests and services in India.

541299

₹18.00

7D

0%

1Y

n/a

N G Industries

₹547.0m

Provides various healthcare services in India.

530897

₹163.25

7D

-2.7%

1Y

-2.5%